-- 根據週四提交給上海證券交易所的文件，人福醫藥（SHA:600079）第一季歸屬於母公司股東的淨利潤年增8.9%，達到5.882億元人民幣，去年同期為5.403億元。 該公司每股收益較去年同期成長9.1%，達0.36元人民幣，去年同期為0.33元。 營業收入較去年同期下滑至61億元，去年同期為61.4億元。
Related Articles
Research
Rothschild & Co Redburn Initiates Coherent at Buy With $455 Price Target
Coherent (COHR) has an average rating of overweight and mean price target of $320.02, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$COHR
Research
Rothschild & Co Redburn Initiates Ciena at Buy With $1,270 Price Target
Lumentum Holdings (LITE) has an average rating of overweight and mean price target of $861.19, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$LITE
Research
Rothschild & Co Redburn Initiates Ciena at Neutral With $416 Price Target
Ciena (CIEN) has an average rating of overweight and mean price target of $409.76, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$CIEN